Author:
Yang Mengting,Zhang Puwen,Halladay Jillian,Zou Kun,Choonara Imti,Ji Xiaorui,Zhang Shuya,Yan Weiyi,Huang Liang,Lu Xiaoxi,Wang Huiqing,Jiang Yuxin,Liu Xinyu,Zeng Linan,Zhang Lingli,Guyatt Gordon H.
Funder
the medical cross key project of Sichuan University, China
Publisher
Springer Science and Business Media LLC
Reference154 articles.
1. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7(2):204–15. https://doi.org/10.1111/j.1524-4733.2004.72252.x.
2. U.S. Food and Drug Administration (FDA). FDA patient-focused drug development guidance series for enhancing the incorporation of the patient’s voice in medical product development and regulatory decision making. 2018–2023. [Online]. Available at: https://www.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical. Accessed 18 Aug 2023.
3. European Medicines Agency Committee for Medicinal Products for Human Use. 2 to the Guideline on the Evaluation of Anticancer Medicinal Products in Man: The Use of Patient-Reported Outcome (PRO) Measures in Oncology Studies EMA/CHMP/292464/2014. London, England: European Medicines Agency; 2016.
4. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290(12):1624–32. https://doi.org/10.1001/jama.290.12.1624.
5. Barbosa CD, Balp MM, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39–48. https://doi.org/10.2147/ppa.S24752.